Imatinib Regimen
A chemotherapy regimen consisting of imatinib that may be used in the treatment of bone cancer; chronic myeloid leukemia (CML); pigmented villonodular synovitis (PVNS), tenosynovial giant cell, gastrointestinal (GI) stromal, and desmoid tumors (aggressive fibromatoses); dermatofibrosarcoma protuberans (DFSP); AIDS-related Kaposi sarcoma; cutaneous melanoma; and systemic mastocytosis. [ ]
Term info
Imatinib Regimen
- Gleevec Regimen
- Imatinib Mesylate Regimen
- Imatinib Regimen
NCIT_C160951, NCIT_C160950
Imatinib Regimen
Therapeutic or Preventive Procedure
C160054
Term relations
- Regimen Used to Treat Mastocytosis
- Regimen Used to Treat Malignant Intestinal Neoplasm
- Regimen Used to Treat Chronic Myeloid Leukemia
- Regimen Used to Treat Malignant Soft Tissue Neoplasm
- Regimen Used to Treat Bone Cancer
- Regimen Used to Treat Kaposi Sarcoma
- Regimen Used to Treat Melanoma
- Chemotherapy_Regimen_Has_Component some Imatinib Mesylate